We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

263 hedge funds and large institutions have $2.61B invested in Emergent Biosolutions in 2020 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 87 increasing their positions, 95 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

150% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 20

11% more funds holding

Funds holding: 236 → 263 (+27)

7% more capital invested

Capital invested by funds: $2.43B → $2.61B (+$181M)

0.25% more ownership

Funds ownership: 87.12% → 87.37% (+0.25%)

8% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 95

37% less call options, than puts

Call options by funds: $1.49M | Put options by funds: $2.36M

Holders
263
Holders Change
+27
Holders Change %
+11.44%
% of All Funds
5.8%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.11%
New
50
Increased
87
Reduced
95
Closed
20
Calls
$1.49M
Puts
$2.36M
Net Calls
-$874K
Net Calls Change
+$1.21M

Top Buyers

1
EARNEST Partners
EARNEST Partners
Georgia
+$43.1M
2
Invesco
Invesco
Georgia
+$17.5M
3
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$16.5M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$15.2M
5
CRCP
Copper Rock Capital Partners
Massachusetts
+$11.3M

Top Sellers

1
RHJA
Rice Hall James & Associates
California
-$19.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.7M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$16.2M
4
BlackRock
BlackRock
New York
-$9.92M
5
Lazard Asset Management
Lazard Asset Management
New York
-$9.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$385M -$9.92M -172,191 -3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$274M +$4.16M +72,160 +2%
EARNEST Partners
3
EARNEST Partners
Georgia
$161M +$43.1M +747,724 +37%
Neuberger Berman Group
4
Neuberger Berman Group
New York
$136M -$5.65M -98,040 -4%
State Street
5
State Street
Massachusetts
$126M +$6.39M +110,892 +5%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$73.2M -$2.63M -45,710 -3%
Northern Trust
7
Northern Trust
Illinois
$61.4M +$1.56M +27,082 +3%
SCM
8
Snyder Capital Management
California
$59.7M -$7M -121,512 -11%
Goldman Sachs
9
Goldman Sachs
New York
$55.9M -$9.17M -159,043 -14%
Invesco
10
Invesco
Georgia
$52.8M +$17.5M +303,427 +50%
Manulife (Manufacturers Life Insurance)
11
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$52.2M +$16.5M +287,074 +47%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$51.1M -$332K -5,769 -0.6%
RHJA
13
Rice Hall James & Associates
California
$44.3M -$19.3M -335,563 -30%
ACM
14
Atlanta Capital Management
Georgia
$41.7M +$8M +138,804 +24%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$37.1M +$2.3M +39,965 +7%
Renaissance Technologies
16
Renaissance Technologies
New York
$36M -$8.13M -141,100 -18%
New York State Common Retirement Fund
17
New York State Common Retirement Fund
New York
$34.8M +$9.33M +161,843 +37%
Fisher Asset Management
18
Fisher Asset Management
Washington
$33.9M -$2.59M -45,026 -7%
Norges Bank
19
Norges Bank
Norway
$32.2M – – –
Jennison Associates
20
Jennison Associates
New York
$30.8M -$6.36M -110,313 -17%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$30.6M -$1.39M -24,149 -4%
Aberdeen Group
22
Aberdeen Group
United Kingdom
$30M -$1.2M -20,875 -4%
Charles Schwab
23
Charles Schwab
California
$29.2M +$323K +5,609 +1%
Wells Fargo
24
Wells Fargo
California
$27.1M +$9.13M +158,422 +51%
Loomis, Sayles & Company
25
Loomis, Sayles & Company
Massachusetts
$25.6M +$15.2M +263,898 +148%
1
2 3 4 5

EBS Hedge Fund Activity: Q1 2020 in Review

263 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2020, worth a combined $2.61B — up 7.5% from $2.43B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new EBS positions and 20 closed out — a net gain of 30 holders — while 87 added to existing stakes and 95 trimmed.

The largest buyer was EARNEST Partners, adding an estimated $43.1M. The largest seller was Rice Hall James & Associates, cutting an estimated $19.3M.

  • 263 institutional investors held Emergent Biosolutions (EBS) as of Q1 2020, up from 236 in Q4 2019.
  • Funds reported $2.61B of Emergent Biosolutions stock for Q1 2020, up 7.5% quarter-over-quarter.
  • 50 funds opened new Emergent Biosolutions positions in Q1 2020 and 20 closed out, a net change of +30 holders.
  • The largest Emergent Biosolutions buyer in Q1 2020 was EARNEST Partners, an estimated $43.1M added.
  • The largest Emergent Biosolutions seller in Q1 2020 was Rice Hall James & Associates, an estimated $19.3M sold.

Based on aggregated 13F filings for Q1 2020.